These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 14403108)

  • 1. Specific liver and brain monoamine oxidase inhibition by alkyl- and arylalkylhydrazines.
    HORITA A; McGRATH WR
    Proc Soc Exp Biol Med; 1960 Apr; 103():753-7. PubMed ID: 14403108
    [No Abstract]   [Full Text] [Related]  

  • 2. The route of administration of some hydrazine compounds as a determinant of brain and liver monoamine oxidase inhibition.
    HORITA A
    Toxicol Appl Pharmacol; 1961 Jul; 3():474-80. PubMed ID: 13715854
    [No Abstract]   [Full Text] [Related]  

  • 3. Histochemical demonstration in rat of monoamine oxidase inhibition of beta-phenyl-isopropyl hydrazine.
    MUSTAKALLIO KK; LEVONEN E; RAEKALLIO J
    Science; 1961 Aug; 134(3475):344. PubMed ID: 13727138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on monoamine oxidase. 2: p-Methylphenyl hydrazine, a potent and selective monoamine oxidase inhibitor.
    ARAI A
    Jpn J Pharmacol; 1960 Mar; 9():159-68. PubMed ID: 13683948
    [No Abstract]   [Full Text] [Related]  

  • 5. Significance of monoamine oxidase inhibition for the pharmacological and clinical effects of hydrazine derivatives.
    PLETSCHER A
    Ann N Y Acad Sci; 1959 Sep; 80():1039-45. PubMed ID: 14433482
    [No Abstract]   [Full Text] [Related]  

  • 6. In vivo monoamine oxidase inhibition measured by potentiation of tryptamine convulsions in rats.
    TEDESCHI DH; TEDESCHI RE; FELLOWS EJ
    Proc Soc Exp Biol Med; 1960 Apr; 103():680-2. PubMed ID: 13837257
    [No Abstract]   [Full Text] [Related]  

  • 7. The inhibition of monoamine oxidase by arylalkylhydrazines.
    GREEN AL
    Biochem J; 1962 Jul; 84(1):217-23. PubMed ID: 13901395
    [No Abstract]   [Full Text] [Related]  

  • 8. [Inhibition "in vitro" of monoamine oxidase].
    NARANJO R
    Rev Asoc Medica Mex; 1960 Jun; 40():272-9. PubMed ID: 14426018
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of the in vivo inhibition of brain and liver monoamine oxidase as produced by beta-phenylisopropylhydrazine (PIH) and iproniazid.
    GOGERTY JH; HORITA A
    J Pharmacol Exp Ther; 1960 Aug; 129():357-60. PubMed ID: 13850477
    [No Abstract]   [Full Text] [Related]  

  • 10. Some remarks about monoamine oxidase and monoamine oxidase inhibitors.
    ZELLER EA
    J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():125-30. PubMed ID: 13788170
    [No Abstract]   [Full Text] [Related]  

  • 11. Reversal of the reserpine-induced depletion of brain serotonin by a monoamine oxidase inhibitor.
    CANAL N; MAFFEI-FACCIOLI A
    J Neurochem; 1959 Dec; 5():99-100. PubMed ID: 13807360
    [No Abstract]   [Full Text] [Related]  

  • 12. The pharmacological evaluation of monoamine oxidase inhibitors.
    LESSIN AW
    Biochem Pharmacol; 1959 Nov; 2():290-8. PubMed ID: 14416030
    [No Abstract]   [Full Text] [Related]  

  • 13. Anticonvulsant properties of monoamine oxidase inhibitors.
    PROCKOP DJ; SHORE PA; BRODIE BB
    Ann N Y Acad Sci; 1959 Sep; 80():643-51. PubMed ID: 14434994
    [No Abstract]   [Full Text] [Related]  

  • 14. Biochemical and pharmacological effects of the monoamine oxidase inhibitors, iproniazid, 1-phenyl-2-hydrazinopropane (JB 516) and 1-phenyl-3-hydrazinobutane (JB 835).
    SPECTOR S; SHORE PA; BRODIE BB
    J Pharmacol Exp Ther; 1960 Jan; 128():15-21. PubMed ID: 13833205
    [No Abstract]   [Full Text] [Related]  

  • 15. Theoretic background of therapy with monoamine oxidase inhibitors in cardiology.
    ZBINDEN G
    Am J Cardiol; 1960 Dec; 6():1121-4. PubMed ID: 13788034
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacological properties of a new inhibitor of monoamine oxidase: 2-hydrazino-1-phenylpropane].
    GENOVESE E; ARRIGONI-MARTELLI E; FRESIA P
    Farmaco Sci; 1959 Jul; 14():516-26. PubMed ID: 13849925
    [No Abstract]   [Full Text] [Related]  

  • 17. An in vivo test for measuring monoamine oxidase inhibition in human subjects.
    RESNICK O; HAGOPIAN M; HOAGLAND H; FREEMAN H
    AMA Arch Gen Psychiatry; 1960 Apr; 2():459-61. PubMed ID: 14437446
    [No Abstract]   [Full Text] [Related]  

  • 18. Monoamine oxidase inhibitors. I. 1-Alkyl and 1-aralkyl-2-(picolinoyl and 5-methyl-3-isoxazolyl-carbonyl)hydrazines.
    GARDNER TS; WENIS E; LEE J
    J Med Pharm Chem; 1960 Apr; 2():133-45. PubMed ID: 13826540
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies on monoamine oxidase. 5. Enzymic differences in the monoamine oxidases in the brain and liver].
    Tatsuo F
    Nihon Yakurigaku Zasshi; 1968 Jul; 64(4):393-8. PubMed ID: 4387722
    [No Abstract]   [Full Text] [Related]  

  • 20. [EFFECT OF ALPHA-SUBSTITUTED BETA-(2-METHYL-3-INDOLYL)-PROPIONIC ACID HYDRAZIDES ON THE ACTIVITY OF BRAIN MONOAMINO OXIDASES].
    SAFRAZBEKIAN RR; SUKASIAN RS
    Farmakol Toksikol; 1964; 27():213-7. PubMed ID: 14193091
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.